Glick B, Lain E, Lin T, Israel R. Efficacy of Halobetasol 0.01%/Tazarotene 0.045% (HP/TAZ) Fixed Combination in the Treatment of Moderate Plaque Psoriasis: Indirect Comparison Between Pooled Phase 3 Trials of HP/TAZ and Oral Treatment (Apremilast). J of Skin [Internet]. 2019 Nov. 9 [cited 2024 Jul. 22];3:S30. Available from: https://jofskin.org/33014/index.php/skin/article/view/757